AIM IMMUNOTECH INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
AIM IMMUNOTECH INC. (AIM) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $2.93 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-08-07
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.93M.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $750.00K.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.29M.
- 2025-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.39M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $2.93M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $750.00K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $2.29M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.39M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $750.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.25M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |